Project

Validating C. elegans healthspan model for better understanding factors causing health disease, to develop evidence based prevention, diagnostic

Acronym
Ageing with elegans
Code
41G04515
Duration
01 May 2015 → 31 October 2020
Funding
European funding: framework programme
Research disciplines
  • Natural sciences
    • Animal cell and molecular biology
Keywords
ageing
Other information
 
Project description

Healthspan (the life period when one is generally healthy and free from serious disease) depends on nature (genetic make-up) and nurture (environmental influences, from the earliest stages of development throughout life). Genetic studies increasingly reveal mutations and polymorphisms that may affect healthspan. Similarly, claims abound
about lifestyle modifications or treatments improving healthspan. In both cases, rigorous testing is hampered by the long lifespan of model organisms like mice (let alone humans) and the difficulty of introducing genetic changes to examine the phenotype of the altered genome. We will develop C. elegans as a healthspan model. Already validated extensively as an ageing model, this organism can be readily modified genetically, and effects of environmental manipulations on healthspan can be measured in days or weeks. Once validated as a healthspan model, it can be used for an initial assessment of preventive and therapeutic measures for humans, as well as for risk identification and the initial evaluation of potential biomarkers. It will also prove useful to study interactions between genetic and various environmental factors.

 
Role of Ghent University
Taking advantage of the WorMotel setup, life trajectories of individual animals are followed up by other partners. Candidate genes and compounds will be selected and the Ghent University partner will evaluate locomotion of treated animals as a proxy for general health at each day of their adult life. Out of the results of an RNAi-based screen, genetic modifiers of a disproportionate health/lifespan are selected for in-depth evaluation. Reporter panels (UGent) and omics analyses (other partners) assist in the grouping of healthspan-modifying interventions and reveal relevant molecular changes. Other phenotypic readouts, such as age-related neuronal function or pathogen resistance, are evaluated as well. Taken together, these experiments provide